Screener
Edwards Lifesciences EW Preferred Stock, Shares Authorized
Preferred Stock, Shares Authorized at other companies
Other financials
Where this comes from
Reported directly by Edwards Lifesciences in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesAuthorized.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
| Line item | March 31,2026 | December 31,2025 |
|---|---|---|
| Total liabilities | 2,993.7 | 3,359.6 |
| Commitments and contingencies (Note 12) | ||
| Stockholders' equity | ||
| Preferred stock, $0.01 par value, authorized 50.0 shares, no shares outstanding | — | — |
| Common stock, $1.00 par value, 1,050.0 shares authorized, 660.0 and 658.7 shares issued, and 577.0 and 580.7 shares outstanding, respectively | 660.0 | 658.7 |
| Additional paid-in capital | 2,781.5 | 2,768.4 |
| Retained earnings | 14,621.2 | 14,240.5 |
| Accumulated other comprehensive loss (Note 13) | (221.3) | (238.3) |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Edwards Lifesciences's preferred stock, shares authorized?
- Edwards Lifesciences (EW) reported preferred stock, shares authorized of 50M in Q1 2026.
- How has Edwards Lifesciences's preferred stock, shares authorized changed year-over-year?
- Edwards Lifesciences's preferred stock, shares authorized decreased by 0.0% year-over-year, from 50M to 50M.
- What is the long-term trend for Edwards Lifesciences's preferred stock, shares authorized?
- Over 5 years (2020 to 2025), Edwards Lifesciences's preferred stock, shares authorized has grown at a 0.0% compound annual growth rate (CAGR), from 50M to 50M.
Ask your AI about Edwards Lifesciences's preferred stock, shares authorized.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude